Clinical Trials for Prinicipal Investigator: Leslie Randall

3 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-15-78 An Open-Label, Phase I/II, Dose-Escalation Study Evaluating The Safety And Tolerability of GDC-0032 In Patients With Locally Advanced Or Metastatic Solid Tumors Or Non-Hodgkin's Lymphoma And In Combination With Endocrine Therapy In Patients With Locally Advanced Or Metastatic Hormone Receptor-Positive Breast Cancer Open
UCI-16-25 A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) In Combination with and/or Following Chemotherapy in Patients with Previously Untreated Epithelial Ovarian Cancer (Javelin Ovarian 100) Open
UCI-16-53 FOCUS: A Multicenter, Multinational, Double-blind, 2-Arm, Randomized, Phase 2/3, Study of Physician's Choice Chemotherapy (PCC) (Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects with Platinum-Resistant, Recurrent, Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer Open